Matthew Hamilton Rosenberg’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$14.7K Buy
+54
New +$14K ﹤0.01% 595
2023
Q4
– Sell
-147
Closed -$21.5K – 937
2023
Q3
$21.5K Hold
147
– – 0.01% 524
2023
Q2
$22.5K Hold
147
– – 0.01% 529
2023
Q1
$22.8K Hold
147
– – 0.01% 570
2022
Q4
$22.7K Hold
147
– – 0.01% 562
2022
Q3
$19K Hold
147
– – 0.01% 568
2022
Q2
$20K Hold
147
– – 0.01% 573
2022
Q1
$22K Hold
147
– – 0.01% 548
2021
Q4
$24K Hold
147
– – 0.01% 509
2021
Q3
$24K Hold
147
– – 0.01% 487
2021
Q2
$25K Hold
147
– – 0.01% 451
2021
Q1
$24K Hold
147
– – 0.01% 425
2020
Q4
$25K Hold
147
– – 0.02% 402
2020
Q3
$23K Hold
147
– – 0.02% 383
2020
Q2
$25K Buy
+147
New +$23.1K 0.02% 392

Other funds holding FBT

Matthew Hamilton Rosenberg's FBT Position: Q3 2026 in Review

Matthew Hamilton Rosenberg opened a new position in First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q3 2026: 54 shares worth $14.7K. The stake represents ﹤0.01% of the portfolio and ranks #595 among its holdings. This is a return to the name: Matthew Hamilton Rosenberg previously reported a position in FBT as recently as Q3 2023.

Matthew Hamilton Rosenberg first reported a position in FBT in Q2 2020 and has held it in 15 quarters since. The position peaked at $25K in Q2 2021. 350 funds tracked by Wall St. Rank hold FBT as of Q3 2026.

  • Matthew Hamilton Rosenberg held 54 shares of First Trust NYSE Arca Biotechnology Index Fund worth $14.7K as of Q3 2026.
  • First Trust NYSE Arca Biotechnology Index Fund was a new Matthew Hamilton Rosenberg position in Q3 2026.
  • First Trust NYSE Arca Biotechnology Index Fund made up ﹤0.01% of Matthew Hamilton Rosenberg's portfolio in Q3 2026, its #595 holding.
  • Matthew Hamilton Rosenberg first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2020 and has held it in 15 quarters since.
  • Matthew Hamilton Rosenberg's First Trust NYSE Arca Biotechnology Index Fund position peaked at $25K in Q2 2021.
  • 350 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2026.

Based on Matthew Hamilton Rosenberg's 13F filing for Q3 2026, filed 5 Oct 2026.